Q32 Bio (QTTB) Operating Leases (2020 - 2026)
Q32 Bio (QTTB) posted quarterly Operating Leases of $4.8 million for Q1 2026, down 13.04% year-over-year from $5.5 million in Q1 2025, and down 3.82% quarter-over-quarter from $4.9 million in Q4 2025.
Q32 Bio (QTTB) Operating Leases (2020 - 2026) Analysis & Trends
Q32 Bio's Operating Leases history runs 7 years deep, the most recent figure standing at $4.8 million for Q1 2026.
- In Q1 2026, Operating Leases fell 13.04% year-over-year to $4.8 million; the TTM figure through Mar 2026 stood at $4.8 million (down 13.04% YoY), while the FY2025 annual figure was $4.9 million, down 12.3% from the prior year.
- Operating Leases for Q1 2026 stood at $4.8 million, down from $4.9 million in the prior quarter.
- The five-year high for Operating Leases was $28.3 million in Q3 2022, with the low at $4.8 million in Q1 2026.
- The 5-year median for Operating Leases is $6.1 million (2024), against an average of $14.1 million.
- The sharpest annual moves came in 2022 and 2024: Operating Leases jumped 144.67% in 2022, then tumbled 78.19% in 2024.
- Q32 Bio's Operating Leases stood at $27.9 million in 2022, then plunged by 77.62% to $6.2 million in 2023, then declined by 9.8% to $5.6 million in 2024, then fell by 12.3% to $4.9 million in 2025, then slipped by 3.82% to $4.8 million in 2026.
- Business Quant data shows QTTB's Operating Leases at $4.8 million in Q1 2026, $4.9 million in Q4 2025, and $5.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Q32 Bio | 359.61 Mn | 253.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.56 Mn |
| Mar 31, 2026 | 4.75 Mn |
| Dec 31, 2025 | 4.94 Mn |
| Sep 30, 2025 | 5.12 Mn |
| Jun 30, 2025 | 5.30 Mn |
| Mar 31, 2025 | 5.47 Mn |
| Dec 31, 2024 | 5.64 Mn |
| Sep 30, 2024 | 5.79 Mn |
| Jun 30, 2024 | 5.95 Mn |
| Mar 31, 2024 | 6.10 Mn |
| Dec 31, 2023 | 6.25 Mn |
| Sep 30, 2023 | 26.56 Mn |
| Jun 30, 2023 | 27.02 Mn |
| Mar 31, 2023 | 27.48 Mn |
| Dec 31, 2022 | 27.92 Mn |
| Sep 30, 2022 | 28.34 Mn |
| Jun 30, 2022 | 23.59 Mn |
| Mar 31, 2022 | 23.55 Mn |
| Dec 31, 2021 | 23.69 Mn |
| Sep 30, 2021 | 11.58 Mn |